메뉴 건너뛰기




Volumn 6, Issue 5, 2004, Pages 399-403

International travel: Recommendations for the HIV-infected patient

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; BCG VACCINE; BISMUTH SALICYLATE; CD4 ANTIGEN; CIPROFLOXACIN; DIPHTHERIA TETANUS TOXOID; DOXYCYCLINE; FUNGUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; LOPERAMIDE; MEASLES MUMPS RUBELLA VACCINE; MEFLOQUINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE VACCINE; PRIMAQUINE; RABIES VACCINE; RITONAVIR; YELLOW FEVER VACCINE; ZIDOVUDINE;

EID: 7944227075     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-004-0040-3     Document Type: Review
Times cited : (5)

References (20)
  • 1
    • 0034571840 scopus 로고    scopus 로고
    • The human immunodeficiency virus-infected traveler
    • Castelli F, Patroni A: The human immunodeficiency virus-infected traveler. Clin Infect Dis 2000, 31: 403-1408.
    • (2000) Clin. Infect. Dis. , vol.31 , pp. 1403-1408
    • Castelli, F.1    Patroni, A.2
  • 2
    • 2942731737 scopus 로고    scopus 로고
    • Travel advice for HIV-infected individuals
    • McKenzie R: Travel advice for HIV-infected individuals. Hopkins HIV Rep 2004, 16:9-12.
    • (2004) Hopkins HIV Rep. , vol.16 , pp. 9-12
    • McKenzie, R.1
  • 3
    • 0034237177 scopus 로고    scopus 로고
    • Antibody response after influenza vaccination in HIV-infected individuals: A consecutive 3-year study
    • Kroon FP, van Dissel JT, de Jong JC, et al.: Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 2000, 18: 040-3049.
    • (2000) Vaccine , vol.18 , pp. 3040-3049
    • Kroon, F.P.1    van Dissel, J.T.2    de Jong, J.C.3
  • 4
    • 2542480178 scopus 로고    scopus 로고
    • Hepatitis A and B vaccination practices for ambulatory patients infected with HIV
    • Tedaldi EM, Baker RK, Moorman AC, et al.: Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 2004, 38:1478-1484.
    • (2004) Clin. Infect. Dis. , vol.38 , pp. 1478-1484
    • Tedaldi, E.M.1    Baker, R.K.2    Moorman, A.C.3
  • 5
    • 0032722361 scopus 로고    scopus 로고
    • Vaccination and HIV: A review of the literature
    • Rousseau MC, Moreau J, Delmont J: Vaccination and HIV: a review of the literature. Vaccine 2000, 18:825-831.
    • (2000) Vaccine , vol.18 , pp. 825-831
    • Rousseau, M.C.1    Moreau, J.2    Delmont, J.3
  • 6
    • 0032973536 scopus 로고    scopus 로고
    • Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: Impact on plasma levels of HIV type 1 RNA and determinants of antibody response
    • Fuller JD, Craven DE, Steger KA, et al.: Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999, 28:541-547.
    • (1999) Clin. Infect. Dis. , vol.28 , pp. 541-547
    • Fuller, J.D.1    Craven, D.E.2    Steger, K.A.3
  • 7
    • 0033592341 scopus 로고    scopus 로고
    • Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial
    • Tasker SA, Treanor JJ, Paxton WB, Wallace MR: Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 131:430-433.
    • (1999) Ann. Intern. Med. , vol.131 , pp. 430-433
    • Tasker, S.A.1    Treanor, J.J.2    Paxton, W.B.3    Wallace, M.R.4
  • 8
    • 84942481233 scopus 로고
    • Epidemiology and prevention of hepatitis A in travelers
    • Steffen R, Kane MA, Shapiro CN, et al.: Epidemiology and prevention of hepatitis A in travelers. JAMA 1994, 272: 85-889.
    • (1994) JAMA , vol.272 , pp. 885-889
    • Steffen, R.1    Kane, M.A.2    Shapiro, C.N.3
  • 10
    • 7644231605 scopus 로고    scopus 로고
    • Recommended adult immunization schedule - United States, 2003-2004
    • Recommended adult immunization schedule - United States, 2003-2004. MMWR Morb Mortal Wkly Rep 2003, 52:965-970.
    • (2003) MMWR Morb. Mortal Wkly. Rep. , vol.52 , pp. 965-970
  • 11
    • 2042503029 scopus 로고    scopus 로고
    • Yellow fever vaccine is safe and effective in HIV-infected patients
    • Tattevin P, Depatureaux AG, Chapplain JM, et al.: Yellow fever vaccine is safe and effective in HIV-infected patients. AIDS 2004, 18:825-827.
    • (2004) AIDS , vol.18 , pp. 825-827
    • Tattevin, P.1    Depatureaux, A.G.2    Chapplain, J.M.3
  • 12
    • 0034609280 scopus 로고    scopus 로고
    • Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity
    • Cobelens FG, van Deutekom H, Draayer-Jansen IW, et al.: Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000, 356: 61-465.
    • (2000) Lancet , vol.356 , pp. 461-465
    • Cobelens, F.G.1    van Deutekom, H.2    Draayer-Jansen, I.W.3
  • 13
    • 0030949154 scopus 로고    scopus 로고
    • Disseminated bacille Calmette-Guerin disease after vaccination: Case report and review
    • Talbot EA, Perkins MD, Silva SF, Frothingham R: Disseminated bacille Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis 1997, 24:1139-1146.
    • (1997) Clin. Infect. Dis. , vol.24 , pp. 1139-1146
    • Talbot, E.A.1    Perkins, M.D.2    Silva, S.F.3    Frothingham, R.4
  • 14
    • 0034830724 scopus 로고    scopus 로고
    • Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
    • Khaliq Y, Gallicano K, Tisdale C, et al.: Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers. Br J Clin Pharmacol 2001, 51:591-600.
    • (2001) Br. J. Clin. Pharmacol. , vol.51 , pp. 591-600
    • Khaliq, Y.1    Gallicano, K.2    Tisdale, C.3
  • 15
    • 0032826183 scopus 로고    scopus 로고
    • Antiretroviral treatment and travel to developing countries
    • Colebunders R, Nchega J, Van Gompel A: Antiretroviral treatment and travel to developing countries. J Travel Med 1999, 6:27-31.
    • (1999) J. Travel Med. , vol.6 , pp. 27-31
    • Colebunders, R.1    Nchega, J.2    Van Gompel, A.3
  • 17
    • 0037076755 scopus 로고    scopus 로고
    • Guidelines for preventing opportunistic infection among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America
    • Kaplan JE, Masur H, Holmes KK, et al.: Guidelines for preventing opportunistic infection among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51: -52.
    • (2002) MMWR Recomm. Rep. , vol.51 , pp. 1-52
    • Kaplan, J.E.1    Masur, H.2    Holmes, K.K.3
  • 18
    • 7944225252 scopus 로고    scopus 로고
    • National Center for Infectious Diseases - Travelers' health
    • Centers for Disease Control and Prevention Accessed June 14
    • Centers for Disease Control and Prevention: National Center for Infectious Diseases - travelers' health. http://www.cdc.gov/travel. Accessed June 14, 2004.
    • (2004)
  • 19
    • 84869978386 scopus 로고    scopus 로고
    • Medical information for Americans traveling abroad
    • United States Department of State Accessed June 14
    • United States Department of State: Medical information for Americans traveling abroad. http://www.travel.state.gov/medical.html. Accessed June 14, 2004.
    • (2004)
  • 20
    • 0003864029 scopus 로고    scopus 로고
    • International travel and health
    • World Heath Organization Accessed June 14
    • World Heath Organization: International travel and health. http://www.who.int/ith. Accessed June 14, 2004.
    • (2004)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.